Investors Who Rotated Out of Tech Are Already Regretting It. This Artificial Intelligence (AI) Growth Stock Is Up Double Digits in May.

Nebius has more than $20 billion in contracted backlog, including up to $19.4 billion from Microsoft and $12 billion from Meta with an option to $27 billion, supporting a rapid ARR ramp from $1.25 billion to $7 billion-$9 billion by year-end 2026. The company is benefiting from strong AI infrastructure demand and customer prepayments that fund over 60% of its planned $16 billion-$20 billion capex, though execution risk and customer concentration remain significant. Shares have already risen more than 35% in May, reflecting investor enthusiasm for the growth story despite the risks.

Analysis

NBIS is behaving less like a normal software multiple story and more like a pre-funded infrastructure project with embedded customer financing. The key second-order effect is that customer prepayments and strategic backing from both the hyperscaler side and the chip supplier side reduce classic balance-sheet risk, but they also make the equity much more sensitive to any slippage in delivery: once capacity is already “sold,” missed rack availability becomes a revenue timing event rather than a demand question.

The market is likely underestimating the option value in the non-core assets, but overestimating how fungible that value is in a downside tape. ClickHouse, Avride, and Toloka provide a valuation floor only if management can avoid forced monetization; in a risk-off drawdown, those stakes may be marked conservatively or become liquidity sources at discount. That means NBIS can still outperform on good execution, yet the left tail is amplified because the bull case depends on multiple simultaneities: power, GPUs, construction, and customer retention all have to work in the same quarter.

For MSFT and META, this is less about incremental AI spend and more about supply-chain insurance. If NBIS can reliably turn prepayments into capacity, it reduces near-term GPU scarcity pressure for both, but it also exposes them to vendor concentration risk if the relationship becomes strategically sticky and expensive. For NVDA, the signal is mildly positive but not linear: a funded, fast-growing customer base supports volume, though any bottleneck at the data-center layer could delay chip shipment monetization into later quarters.

The contrarian view is that consensus may be too anchored on headline backlog and too relaxed about cadence. A six- to seven-fold ARR jump in one year is not just aggressive; it implies near-perfect conversion from contracted to operating capacity, so the stock should trade with event risk around build milestones and quarterly commentary rather than as a steady compounding story.

Key Decisions for Investors

• Stay tactically long NBIS into the next earnings print only via call spreads or a limited-risk call structure; the setup offers upside if delivery is on track, but the event carries meaningful gap risk if management hedges 2026 capacity timing.
• Use any post-earnings strength to trim naked long NBIS exposure and rotate into a pairs structure: long MSFT / short NBIS on the thesis that hyperscaler balance sheets capture more durable AI spend with less single-name execution risk.
• Buy NVDA on dips rather than chasing NBIS; if Nebius executes, NVIDIA still benefits from deployment volume, but with far less balance-sheet and customer-concentration risk.
• For more defensive exposure, prefer META over NBIS on a 3-6 month horizon; if the contract is strategic, META is effectively outsourcing capacity while preserving optionality, whereas NBIS is underwriting build-out execution.